查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1969943

2026-2034年全球急性肺損傷治療市場規模、佔有率、趨勢和成長分析報告

Global Acute Lung Injury Treatment Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 112 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計急性肺損傷治療市場將從 2025 年的 39.8 億美元成長到 2034 年的 53.5 億美元，2026 年至 2034 年的複合年成長率為 3.34%。

由於感染疾病、環境污染和慢性病等因素導致的呼吸系統疾病日益增多，全球急性肺損傷（ALI）治療市場正在不斷擴大。急性肺損傷通常是嚴重、創傷或敗血症的併發症，導致住院率上升。醫護人員對早期診斷和快速治療的認知不斷提高，正在改善患者預後，並推動全球治療方法的普及。

市場成長的主要驅動力是藥物治療方法的進步，包括抗發炎藥物、皮質類固醇和呼吸輔助性治療。針對標靶治療和再生醫學的研究活動正在蓬勃發展。臨床試驗的增加以及製藥公司與研究機構之間合作的加強正在加速創新。此外，發展中地區醫療基礎設施的改善也有助於提高患者獲得治療的機會。

展望未來，個人化醫療方法和旨在更有效地減輕肺部發炎的生物製藥療法有望推動市場成長。呼吸系統研究投入的增加和政府扶持政策的推出將進一步促進市場成長。隨著全球醫療體系致力於改善重症監護管理，未來幾年對先進急性肺損傷治療的需求預計將穩定成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球急性肺損傷治療市場：依治療方法

  • 市場分析、洞察與預測
  • 人工呼吸器
  • 藥物治療
  • 點滴管理
  • 其他

第5章 全球急性肺損傷治療市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 專業醫療機構
  • 其他

第6章 全球急性肺損傷治療市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Mayo Clinic
    • Johns Hopkins Hospital
    • Cleveland Clinic
    • Great Ormond Street Hospital
    • Apollo Hospitals
    • Tokyo Medical University Hospital
    • The Prince Charles Hospital
    • Helios Hospital
    • Aster Hospitals
簡介目錄
Product Code: VMR112110671

The Acute Lung Injury Treatment Market size is expected to reach USD 5.35 Billion in 2034 from USD 3.98 Billion (2025) growing at a CAGR of 3.34% during 2026-2034.

The Global Acute Lung Injury (ALI) Treatment Market is growing due to the increasing prevalence of respiratory disorders caused by infections, environmental pollution, and chronic diseases. Acute lung injury often develops as a complication of severe illness, trauma, or sepsis, leading to rising hospitalization rates. Greater awareness among healthcare professionals about early diagnosis and prompt treatment has improved patient outcomes and expanded treatment adoption worldwide.

Market growth is mainly driven by advancements in pharmacological therapies, including anti-inflammatory drugs, corticosteroids, and supportive respiratory treatments. Research activities focused on targeted therapies and regenerative medicine approaches are gaining momentum. Increasing clinical trials and collaborations between pharmaceutical companies and research institutes are accelerating innovation. Additionally, improved healthcare infrastructure in developing regions is supporting better access to treatment options.

In the future, the market is expected to benefit from personalized medicine approaches and biologic therapies designed to reduce lung inflammation more effectively. Rising investments in respiratory research and supportive government policies will further enhance market growth. As global healthcare systems focus on improving critical care management, demand for advanced acute lung injury treatments is likely to increase steadily over the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Therapy Types

  • Mechanical Ventilation
  • Pharmacotherapy
  • Fluid Management
  • Others

By End-Users

  • Hospitals
  • Specialty Centers
  • Others

COMPANIES PROFILED

  • Mayo Clinic, Johns Hopkins Hospital, Cleveland Clinic, Great Ormond Street Hospital, Apollo Hospitals, Tokyo Medical University Hospital, The Prince Charles Hospital, Helios Hospital, Aster Hospitals
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET: BY THERAPY TYPES 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Therapy Types
  • 4.2. Mechanical Ventilation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Pharmacotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Fluid Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET: BY END-USERS 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End-users
  • 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Specialty Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Therapy Types
    • 6.2.2 By End-users
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Therapy Types
    • 6.3.2 By End-users
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Therapy Types
    • 6.4.2 By End-users
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Therapy Types
    • 6.5.2 By End-users
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Therapy Types
    • 6.6.2 By End-users
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL ACUTE LUNG INJURY TREATMENT INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Mayo Clinic
    • 8.2.2 Johns Hopkins Hospital
    • 8.2.3 Cleveland Clinic
    • 8.2.4 Great Ormond Street Hospital
    • 8.2.5 Apollo Hospitals
    • 8.2.6 Tokyo Medical University Hospital
    • 8.2.7 The Prince Charles Hospital
    • 8.2.8 Helios Hospital
    • 8.2.9 Aster Hospitals